ViiV Healthcare announced FDA approval of the first-ever dispersible tablet formulation of dolutegravir for children living with HIV
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
On Jun. 11, 2020, a study led by UT Southwestern researchers revealed the structure of the active form…
On Jun. 11, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Jun. 11, 2020, Atossa Therapeutics announced that the manuscript of the results from in vitro testing of AT-H201, Atossa’s…
On Jun. 11, 2020, a team of researchers from the National Library of Medicine identified genomic features of…
On Jun. 11, 2020, Bristol-Myers Squibb announced that Opdivo ® (nivolumab) was approved by the U.S. Food and…
On Jun. 11, 2020, scientists at the National Cancer Institute (NCI) announced they have developed a new test…
On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…
On Jun. 11, 2020, scientists at the Universities of Oxford, Exeter, Yunnan and Bristol announced they had discovered…
On Jun. 11, 2020, Sinovac Biotech announced the signing of a clinical development collaboration agreement to advance the…
On Jun. 11, 2020, Emergent BioSolutions announced deployment of its molecule-to-market contract development and manufacturing (CDMO) services to…
On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…
On Jun. 11, 2020, AIM ImmunoTech announced that it had filed a provisional patent application for, among other…
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
On Jun. 11, 2020, Innovation Pharma and researchers at a U.S. Regional Biocontainment Laboratory (RBL) announced they are…
On Jun. 11, 2020, Regeneron announced announced that Science has accepted for publication two papers describing the creation of…
On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…
On Jun. 10, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…
On Jun. 10, 2020, researchers funded by the National Institutes of Health (NIH) launched an effort to evaluate…
On Jun. 10, 2020, the the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA)…
On Jun. 10, 2020, researchers at Washington University School of Medicine in St. Louis reported they have developed…
On Jun. 10, 2020, Johnson & Johnson announced that through its Janssen Pharmaceutical subsidiary it has accelerated the…
On Jun. 10, 2020, OraSure Technologies announced it had been awarded a $629,217 contract from the Biomedical Advanced…
On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…
On Jun. 10, 2020, RedHill Biopharma announced it had submitted a Clinical Trial Application (CTA) with the Ministry…
On Jun. 9, 2020, an international gnomAD team of over 100 scientists released its first set of discoveries…
On Jun. 9, 2020, Illumina announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization…
On Jun. 9, 2020, Quidel announced that is had received an amended Emergency Use Authorization (EUA) from the…
On Jun. 9, 2020, researchers from Scripps report that an extraordinary percentage of people infected by the virus…
On Jun. 9, 2020, OpGen announced preliminary data from an investigator initiated collaboration with Karolinska Institutet, Stockholm, Sweden,…